Business ❯ Pharmaceuticals

Manufacturing

Investment Job Creation Active Pharmaceutical Ingredients Drug Production Drug Development Facilities Domestic Production Safety Protocols Biologics Reshoring

Bristol Myers Squibb to Build $2.3 Billion Modular Manufacturing Campus in Houston

It anchors BMS’s five-year $40 billion push to expand U.S. drug production.

Lilly and Resilience Announce $750 Million Ohio Expansion for KwikPen and Injectables

Katwijk Council Gives Provisional Backing to Eli Lilly Factory After €100 Million Infrastructure Deal

TheraNyM Biologics Opens ₹1,200 Crore Biologics Plant Near Hyderabad

Grifols Starts Building 80,000 m² Plasma Complex in Lliçà de Vall

Eli Lilly Pours $4.5 Billion Into Indiana Plants, Opens Genetic-Medicine Site

Novartis to Close Wehr Plant by 2028, About 220 Jobs at Risk

Nosch Labs Reactor Blast Injures Nine on Labour Day

AbbVie to Build $1.4 Billion Injectable-Medicines Campus in Durham, N.C.

UCB Picks Georgia’s Rowen for $2 Billion Biologics Campus

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

Blue Jet Healthcare to Break Ground Today on Rs 2,300-Crore Pharma Plant in Andhra Pradesh

Novartis to Build 46,000‑Square‑Foot Radioligand Therapy Plant in Denton, Texas

AbbVie to Invest $380 Million in Two North Chicago API Plants

Toluene Tank Explodes at Ercros’s Aranjuez Plant With No Injuries Reported

Eli Lilly Chooses Pennsylvania for $3.5 Billion Plant to Produce Weight-Loss Injectables

Eli Lilly Picks Lehigh Valley for $3.5 Billion Plant to Make Next-Gen Weight-Loss Drugs

Tanya Mittal Denies '150 Bodyguards' Claim, Opens Pharma Factory to Media

Himachal Raids 20 Dormant Pharma Units as Drugs Are Seized at Unlicensed Bathu Plant

Eli Lilly Picks Huntsville for $6 Billion API Plant to Supply Next-Gen Drugs